Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Unilacto is a nutraceutical galactagogue developed and manufactured by Universal Corporation (UCL) in Kenya. It is specifically formulated to support and enhance breast milk production in lactating mothers who may be experiencing insufficient milk supply (hypogalactia). As part of the Unicare Nutraceuticals range, Unilacto is composed of natural botanical extracts traditionally recognized for their lactogenic properties, such as *Asparagus racemosus* (Shatavari). The product is typically administered orally in a granule formulation and is intended to promote maternal wellness and ensure adequate nutrition for infants by stimulating the physiological pathways involved in lactation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Unilacto.